Women and Bone Health: Maximizing the Benefits of Aromatase Inhibitor Therapy

Publisher： Karger

E-ISSN： 1423-0232|79|1-2|13-26

ISSN： 0030-2414

Source： Oncology, Vol.79, Iss.1-2, 2010-11, pp. : 13-26

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Risk of ovarian function recovery should be considered when switching from treatment with adjuvant tamoxifen to aromatase inhibitor therapy in women with chemotherapy‐induced amenorrhea

By  

CA: A CANCER JOURNAL FOR CLINICIANS, Vol. 68, Iss. 1, 2018-01 ,pp. : 5-6

John Wiley & Sons Inc

Access to resources Recommend Favorite

Managing aromatase inhibitor-associated bone loss in breast cancer

By Lipton Allan   Gnant Michael   Aapro Matti  

Women's Health, Vol. 3, Iss. 4, 2007-07 ,pp. : 441-448

Future Medicine

Access to resources Recommend Favorite

Initial versus sequential adjuvant aromatase inhibitor therapy: a review of the current data

By Ellis Matthew J.   Rigden Caron E.  

Current Medical Research and Opinion, Vol. 22, Iss. 12, 2006-12 ,pp. : 2479-2487

Informa Healthcare

Access to resources Recommend Favorite

Patient‐reported symptoms and discontinuation of adjuvant aromatase inhibitor therapy

By  

CANCER, Vol. 120, Iss. 16, 2014-08 ,pp. : 2403-2411

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pilot study of Iyengar yoga for management of aromatase inhibitor‐associated arthralgia in women with breast cancer

By  

PSYCHO-ONCOLOGY (ELECTRONIC), Vol. 24, Iss. 11, 2015-11 ,pp. : 1578-1580

John Wiley & Sons Inc

Access to resources Recommend Favorite